Dr Reddys Laboratories informs about company updates

09 Mar 2017 Evaluate

Dr Reddys Laboratories has informed that the audit of Company’s formulation manufacturing facilty at Duwada, Visakhapatnam, by the US FDA, has been completed on March 08, 2017. The Company have been issued a Form 483 with 13 observations, which the Company is addressing.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1293.00 -25.75 (-1.95%)
13-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.50
Dr. Reddys Lab 1293.00
Cipla 1314.10
Zydus Lifesciences 906.00
Lupin 2314.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×